HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Junichi Shimizu Selected Research

Ascites

1/2015[Subcutaneous continuous injection of octreotide decreased the tumor marker levels and induced cystic necrosis of the tumors in a case of pancreatic neuroendocrine tumor with multiple hepatic metastases].

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Junichi Shimizu Research Topics

Disease

32Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
11/2023 - 11/2005
16Neoplasms (Cancer)
11/2023 - 11/2005
8Lung Neoplasms (Lung Cancer)
09/2023 - 06/2008
7Neoplasm Metastasis (Metastasis)
04/2021 - 08/2005
6Small Cell Lung Carcinoma (Small Cell Lung Cancer)
04/2022 - 10/2008
5Adenocarcinoma of Lung
03/2021 - 10/2008
4Adenocarcinoma
01/2017 - 10/2008
3Pneumonia (Pneumonitis)
01/2022 - 11/2018
3Interstitial Lung Diseases (Interstitial Lung Disease)
01/2022 - 11/2005
2Disease Progression
11/2017 - 01/2007
2Hepatocellular Carcinoma (Hepatoma)
12/2012 - 08/2005
2Pain (Aches)
09/2011 - 03/2006
1Death (Near-Death Experience)
09/2023
1Brain Neoplasms (Brain Tumor)
05/2023
1Head and Neck Neoplasms (Head and Neck Cancer)
08/2021
1Stomach Neoplasms (Stomach Cancer)
08/2021
1Pulmonary Embolism
08/2021
1Colorectal Neoplasms (Colorectal Cancer)
08/2021
1Liver Diseases (Liver Disease)
05/2021
1Chemical and Drug Induced Liver Injury
05/2021
1Vomiting
03/2021
1Nausea
03/2021
1Idiopathic Pulmonary Fibrosis
01/2020
1Malignant Mesothelioma
11/2019
1Stomatitis
10/2019
1Breast Neoplasms (Breast Cancer)
10/2019
1Paronychia
09/2018
1Inflammation (Inflammations)
11/2017
1Sarcoma (Soft Tissue Sarcoma)
01/2017
1Necrosis
01/2015
1Neuroendocrine Tumors (Neuroendocrine Tumor)
01/2015
1Ascites
01/2015
1Ulcer
09/2013
1Hepatitis
12/2012
1Febrile Neutropenia
09/2011
1Chromosomal Instability (Chromosome Stability)
07/2010

Drug/Important Bio-Agent (IBA)

10ErbB Receptors (EGF Receptor)IBA
11/2023 - 01/2007
6NivolumabIBA
08/2021 - 11/2017
6Gefitinib (Iressa)FDA Link
11/2017 - 11/2005
5Anaplastic Lymphoma KinaseIBA
11/2017 - 02/2014
4Tyrosine Kinase InhibitorsIBA
03/2021 - 01/2009
3pembrolizumabIBA
11/2022 - 11/2018
3Immune Checkpoint InhibitorsIBA
01/2022 - 01/2020
3Monoclonal AntibodiesIBA
08/2021 - 11/2019
3Carboplatin (JM8)FDA LinkGeneric
03/2021 - 06/2008
3CrizotinibIBA
10/2016 - 09/2013
2Bevacizumab (Avastin)FDA Link
08/2021 - 03/2021
2osimertinibIBA
03/2021 - 09/2018
2Cisplatin (Platino)FDA LinkGeneric
01/2018 - 06/2008
2Docetaxel (Taxotere)FDA Link
11/2017 - 09/2011
2Erlotinib Hydrochloride (CP 358,774)FDA Link
11/2017 - 11/2009
2PlatinumIBA
01/2017 - 12/2015
2Messenger RNA (mRNA)IBA
07/2010 - 06/2008
1trastuzumab deruxtecanIBA
11/2023
1NucleotidesIBA
11/2023
1ElementsIBA
09/2023
1lorlatinibIBA
05/2023
1B7-H1 AntigenIBA
11/2022
1Somatostatin Receptors (Somatostatin Receptor)IBA
01/2022
1Pemetrexed (MTA)FDA Link
01/2022
1dabrafenibIBA
01/2022
1trametinibIBA
01/2022
1fibrin fragment D (D-dimer)IBA
08/2021
1FenbendazoleIBA
05/2021
1Olanzapine (Zyprexa)FDA Link
03/2021
1Biomarkers (Surrogate Marker)IBA
01/2020
1Dipeptidyl Peptidase 4 (Dipeptidyl Peptidase IV)IBA
11/2019
1Glycoproteins (Glycoprotein)IBA
11/2019
1EverolimusFDA Link
10/2019
1SteroidsIBA
10/2019
1TOR Serine-Threonine KinasesIBA
10/2019
1AntibodiesIBA
11/2018
1S-1 plus cisplatinIBA
01/2018
1Vinorelbine (Navelbine)FDA LinkGeneric
01/2018
1AfatinibIBA
11/2017
1alectinibIBA
11/2017
1ceritinibIBA
11/2017
1Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA
01/2017
1Octreotide (Sandostatin)FDA LinkGeneric
01/2015
1Tumor Biomarkers (Tumor Markers)IBA
01/2015
1Phosphopyruvate Hydratase (Enolase)IBA
01/2015
1UracilIBA
12/2012
1Granulocyte Colony-Stimulating Factor (G-CSF)IBA
12/2012
1Sorafenib (BAY 43-9006)FDA Link
12/2012
1TegafurIBA
12/2012
1FlavonoidsIBA
09/2011
1vadimezanIBA
09/2011
1ran-binding protein 2IBA
07/2010
1Type II DNA Topoisomerases (Topoisomerase II)IBA
07/2010
1Protein Isoforms (Isoforms)IBA
07/2010
1UbiquitinIBA
07/2010
1Ligases (Synthetase)IBA
07/2010

Therapy/Procedure

16Drug Therapy (Chemotherapy)
09/2023 - 11/2005
9Therapeutics
11/2022 - 04/2010
5Radiotherapy
06/2021 - 01/2007
5Chemoradiotherapy
06/2021 - 01/2018
1Terminal Care (Care, Terminal)
09/2023
1Combination Drug Therapy (Combination Chemotherapy)
08/2021
1Self Administration (Administration, Self)
05/2021
1Segmental Mastectomy (Lumpectomy)
04/2021